Healthcare / Medical Care FacilitiesSaudi
$32.98
+0.46 (+1.41%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 14%
FCF escenarios
weak_data · normalized FCF $-41.3M · quality 25.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
48/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3.0B
P/E
8.1x
↓EV/EBITDA
7.3x
↓ROE
17.3%
↑Gross Margin
38.6%
↓Debt/Equity
1.52
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+15.5%
FCF CAGR
—
FCF margin
9.9%
FCF / Net income
1.02x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.88B · net income $282.0M · FCF $286.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.88B | $2.88B | $2.65B | $2.15B | $1.87B |
| Net Income | $282.0M | $282.0M | $17.0M | $75.2M | $17.2M |
| EBITDA | $747.5M | $747.5M | $533.9M | $296.2M | $202.2M |
| EPS | 3.06 | 3.06 | 0.19 | 0.82 | 0.19 |
| Gross Margin | 38.6% | 38.6% | 38.2% | 31.6% | 32.5% |
| Operating Margin | 15.5% | 15.5% | 12.5% | 6.7% | 3.3% |
| Net Margin | 9.8% | 9.8% | 0.6% | 3.5% | 0.9% |
| Balance Sheet | |||||
| Debt/Equity | 1.52 | 1.52 | 1.88 | 1.69 | 1.56 |
| Current Ratio | 1.48 | 1.48 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $286.7M | $286.7M | $-41.3M | $-173.5M | $-340.9M |
| Returns | |||||
| ROE | 17.3% | 17.3% | 1.3% | 5.7% | 1.4% |
| Valuation | |||||
| P/E | 8.08 | 8.08 | 471.05 | 32.32 | 173.16 |
| EV/EBITDA | 7.29 | 7.29 | 20.00 | 15.75 | 24.57 |
| P/B | 1.87 | 1.87 | 6.24 | 1.84 | 2.41 |
| Growth & Yield | |||||
| Revenue Growth | 8.7% | 8.7% | 23.3% | 14.9% | — |
| EPS Growth | 1510.5% | 1510.5% | -76.8% | 331.6% | — |
| Dividend Yield | 1.5% | 1.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-1.5%
EPS terminal req.
$2.93
Spread vs growth
1512.0%
5Y implied EPS CAGR
3.0%
EPS terminal req.
$3.54
Spread vs growth
1507.6%
10Y implied EPS CAGR
6.4%
EPS terminal req.
$5.70
Spread vs growth
1504.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-42.3%
Start / end P/E
308.9x → 10.8x
EPS bridge
0.19 → 3.06
Residual
-1457.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.